In ESCC models, suppression of glutathione peroxidase 4 (GPX4) and overexpression of ACSL4 have been linked to enhanced sensitivity to ferroptosis-inducing agents [39,40]. The gene discussed is GPX4; the disease is esophageal squamous cell carcinoma.